What's the plan in China for when one of these expedited treatments has a terrible side effect?
The FDA's slowness is about maintaining a low level of risk because the reputation cost of a really bad incident is huge.
The FDA's slowness is about maintaining a low level of risk because the reputation cost of a really bad incident is huge.